Research Paper Volume 16, Issue 10 pp 8822—8842
Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data
Figure 7. Analysis of immunity status of risk groups. (A–D) Immune status and immunotherapy between risk groups. (E–H) Active or suppressive TME between risk groups. (I, J) Exploration of immune checkpoints. (K) Submap analysis. *P <0.05, **P <0.01, ***P <0.001, ****P < 0.0001.